Learning objectives: 

  • Define interstitial lung disease
  • Evaluate progression of interstitial lung disease (ILD)
  • Devise a treatment strategy for ILD
  • Examine future directions in ILD treatment
Session date: 
04/17/2024 - 11:00am to 12:00pm EDT
Location: 
Boston University
United States
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    • 1.00 MA Risk Management
  • 1.00 Participation
Please login or register to take this course.